register

News & Trends - MedTech & Diagnostics

Australian medtech launches first dedicated lung scanner at major congress

Health Industry Hub | December 9, 2022 |

MedTech News: An Australian medtech company unveiled a breakthrough lung scanning device at the 2022 annual meeting of the Radiological Society of North America (RSNA) in Chicago, that integrates fluoroscopy with advanced analytics software.

4DMedical’s XV Scanner provides significant technological and competitive advantages over existing imaging modalities that will improve the quality of life for patients with respiratory issues.

It is the first dedicated lung scanner to provide non-invasive functional insights into breathing lungs, with images that provide unprecedented clinical detail and actionable information.

“In the history of scanning technology, there have been very few fundamentally new approaches introduced since the 1970s and only seven scanning modalities introduced in the past 127 years,” said Andreas Fouras, PhD, founder and CEO of 4DMedical.

“We believe the XV Scanner is the ‘Eighth Modality.’ I’m proud that it represents a meaningful breakthrough in lung scanning and disease diagnostics capability that can help patients struggling with respiratory issues. These include veterans and those suffering from long-term COVID-19. This year’s RSNA meeting is the first opportunity for radiologists and other clinicians to view the XV Scanner in person. It’s clear the $31 billion global lung imaging market is ripe for disruption, and 4DMedical will be a major player in that process.”

Current lung imaging modalities include X-ray, high-res CT, and nuclear medicine. They represent trade-offs between accuracy, sensitivity, cost, and high radiation exposure. Importantly, these modalities don’t provide combined insights into the structure and function of a patient’s lungs at the regional level.

The XV Scanner is the first dedicated lung scanner to provide clinicians with both qualitative and quantitative metrics, including regional ventilation volume, ventilation defect percentage, and ventilation heterogeneity. These metrics are produced as colour-coded images, corresponding to functionality by lung region.

Using the XV Scanner, physicians can detect areas of high and low ventilation with pinpoint accuracy—across all parts of the lung and in all phases of a single breath. The scan takes 5 seconds to perform and delivers less radiation than a typical chest X-ray.

The 4DMedical XV Scanner will now be placed at a major U.S. teaching hospital, providing unique capabilities and functional insights for lung disease research.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Sussan Ley breaks ground as first female opposition leader amid Liberal party shake-up

Sussan Ley breaks ground as first female opposition leader amid Liberal party shake-up

Health Industry Hub | May 14, 2025 |

Sussan Ley has made history as the country’s first female opposition leader, edging out former shadow treasurer Angus Taylor in […]

More


News & Trends - MedTech & Diagnostics

New procedure shows durable impact in type 2 diabetes

New procedure shows durable impact in type 2 diabetes

Health Industry Hub | May 14, 2025 |

Medtech company, Endogenex, has unveiled promising data from an Australian clinical trial that could mark a turning point in type […]

More


News & Trends - Pharmaceuticals

AI rewrites the script on androgen deprivation therapy in prostate cancer

AI rewrites the script on androgen deprivation therapy in prostate cancer

Health Industry Hub | May 14, 2025 |

Artificial intelligence is showing promise in reshaping treatment decisions for men undergoing radiation therapy and androgen deprivation therapy (ADT) for […]

More


News & Trends - MedTech & Diagnostics

MSAC to assess CGM funding for expanded access in diabetes management

MSAC to assess CGM funding for expanded access in diabetes management

Health Industry Hub | May 14, 2025 |

Applications from Abbott Australasia and Australasian Medical & Scientific Limited (AMSL) for public funding of continuous glucose monitoring (CGM) devices […]

More


This content is copyright protected. Please subscribe to gain access.